Ophidion
Developer of gene-silencing therapies designed to treat neurodegenerative diseases following intravenous administration. The company's platform uses a trojan horse strategy to exploit an endogenous re...
Valuation
$0
Share Price
N/A
Total Raised
$4.4M
Last Round
Unknown
Latest Funding Round
Unknown
Investors
+9 other investors